Dr. Lorenz Jellinghaus
- Specialist in Commercial and Corporate Law
Expertise
- Corporate Law
- Mergers & Acquisitions
- Venture Capital / Private Equity
- Commercial and Contract Law
Reputation
- Handelsblatt & Best Lawyers 2020: Dr. Lorenz Jellinghaus is one of the best lawyers in the field of Corporate Law in Germany
- Legal 500 Germany 2020: recommended lawyer
- Handelsblatt & Best Lawyers 2019: Dr. Lorenz Jellinghaus is one of the best lawyers in the field of Corporate Law in Germany
- Legal 500 Germany 2019: recommended lawyer, name of the next generation
- Legal 500 Germany 2018: recommended lawyer, name of the next generation ("stands out through his gaming expertise")
- Legal 500 Germany 2017: recommended lawyer
- Legal 500 Germany 2017: recommended lawyer
- Legal 500 Germany 2016: recommended lawyer (“strong negotiator, thinks creatively and from an entrepreneurial angle”)
- Legal 500 EMEA 2016: recommended lawyer
career
- Studied law in Freiburg im Breisgau and Munich
- Obtained law doctorate at the Max-Planck-Institute for European Legal History in Frankfurt/Main, scholarship of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))
- Admitted to the bar in 2005
- 2005–2010 lawyer at international law firms
- 2010–2012 in-house lawyer at holding level of a large group of Companies in Hamburg
- Joined LUTZ | ABEL in 2012
Recent transactions
- Nitrobox GmbH on financing round in million euro range
- Temedica GmbH on EUR 17m financing round
- Cybus GmbH on single-digit million financing round
- ROCCAT GmbH on selling to Turtle Beach Corporation for USD 19.2m
One of the best lawyers in Corporate Law in Germany.
Handelsblatt & Best Lawyers 2020
Dr. Lorenz Jellinghaus is one of Germany´s leading lawyers "of the next generation" in the area of venture capital.Legal 500 Germany 2019
News
LUTZ | ABEL advises Nitrobox in single-digit million financing round
The software start-up Nitrobox GmbH from Germany announced to have completed a financing round in the single-digit million euro range.
The financing round was led by "NeueCapital Partners" fund from Silicon Valley and Porsche Ventures, the venture capital unit of the Stuttgart-based sports car manufacturer. LUTZ | ABEL advised on the transaction.
The German software start-up Nitrobox GmbH closed a financing round in the single-digit million euro range. "NeueCapital Partners" fund from Silicon Valley and Porsche Ventures, the venture capital unit of the Stuttgart-based sports car manufacturer, took a stake in the company.
Nitrobox has developed a cloud platform which can be used in several sectors for automatic monetization and billing of digital business models. In the field of mobility, Nitrobox is already working with several car manufacturers, including Porsche. The start-up supports the order-to-cash process of new business models: services such as car sharing, functions-on-demand, digital parking tickets or charging services can be fully automated via the Nitrobox platform. The company intends to use the funds from the financing round primarily to further expand its market position in Germany and to prepare for its entry to the US market.
As in previous rounds, LUTZ | ABEL provided legal advice to Nitrobox. The team included the following attorneys: Dr. Lorenz Jellinghaus (Partner, Hamburg) Dr. Sebastian Sumalvico (VC, Munich) and Nina Sophie Osten (VC, Hamburg).
-
LUTZ | ABEL advises in EUR 17 Million Series B round of financing for Temedica
The healthcare start-up Temedica GmbH from Germany announced to have completed a € 17 million Series B financing round.The financing round was led by different MIG-Fonds, Santo Venture Capital, G+J Digital Ventures, Salvia and Bernd Wendeln as investors. LUTZ | ABEL advised on the transaction.
The German healthcare start-up Temedica GmbH, which is based in Munich and was founded by Gloria Seibert and Clemens Kofler, closed a € 17 million Series B financing round. MIG-Fonds, Santo Venture Capital and Salvia lead the round – existing shareholders like G+J Digital Ventures and Bernd Wendeln were additional investors.
Founded in 2016, the start-up develops digital companions (such as apps) to support patients in their healing process and to improve their medical care. Until today Temedica came up with the products pelvina (to strengthen the pelvic base), Mineo (to strengthen the back) as well as Waya (for a healthy nutrition and motion sequence). Further product developments are in the process of planning.
The LUTZ | ABEL team included the following attorneys: The partners Dr. Bernhard Noreisch (Munich) and Dr. Lorenz Jellinghaus (Hamburg) led the transaction. The team further consisted of Claudia Knuth (Labour Law, Hamburg), Andreas Kössel (Labour Law, Munich), Jan-Phillip Kunz (VC, Munich), Nina Sophie Osten (VC, Hamburg), Dr. Cornelius Renner (IT, Data Protection Law, Berlin), Ute Schenn (Commercial, Stuttgart), Dr. André Schmidt (IT, Data Protection Law, Hamburg).
The investors Santo Venture Capital and Salvia were represented by honert + partner (Sven Fritsche, Munich).
